
TELMIWAL-40
MRP: 1,136
Packaging: 10x15
Pack Type: tablet
Composition:
Telmisartan 40mg
Indication:
Coronary Heart Disease, Myocardial Infarction, Essential Hypertension, Angina, Atherosclerosis
Description:
Telmisartan 40mg is an effective antihypertensive medication belonging to the class of angiotensin II receptor blockers (ARBs). It helps in lowering high blood pressure by relaxing blood vessels, allowing blood to flow more easily. This medication is primarily used to manage hypertension and reduce the risk of cardiovascular events such as stroke and heart attack. Telmisartan is also prescribed for patients with certain heart or kidney conditions to protect vital organs from damage due to high blood pressure. The 40mg dosage is suitable for adults requiring moderate blood pressure control.
Tags:
- Effectively lowers high blood pressure
- Reduces risk of heart attack and stroke
- Protects kidney function in patients with hypertension
- Improves blood flow by relaxing blood vessels
- Once-daily dosage for easy adherence
Usage Information
Dosage
Take one 40mg tablet once daily, preferably at the same time each day. Can be taken with or without food. Follow your doctor’s instructions on dose adjustments. Do not stop taking the medication without consulting your healthcare provider.
Side Effects
Common: dizziness, headache, fatigue Less common: nausea, diarrhea, back pain Rare but serious: allergic reactions, swelling of face/lips, severe dizziness If severe side effects occur, seek medical attention immediately.
Contraindications
Hypersensitivity to Telmisartan or any ingredient in the tablet Pregnant or breastfeeding women (consult doctor) Severe liver impairment Patients with bilateral renal artery stenosis Use with caution in patients with kidney disease or low potassium levels
Availability
Telmisartan 40mg Telmisartan tablets Blood pressure medication Hypertension treatment ARB medication Angiotensin receptor blocker Telmisartan benefits Telmisartan side effects Telmisartan dosage High blood pressure medicine
